A. Amirfallah Et Al. , "5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis," ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , İstanbul, Turkey, pp.1, 2012
Amirfallah, A. Et Al. 2012. 5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis. ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , (İstanbul, Turkey), 1.
Amirfallah, A., Çalıbaşı Koçal, G., Ünal, O. Ü., Başbınar, Y., Öztop, İ., Ellidokuz, H., ... Yılmaz, A. U.(2012). 5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis . ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs (pp.1). İstanbul, Turkey
Amirfallah, A Et Al. "5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis," ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs, İstanbul, Turkey, 2012
Amirfallah, A Et Al. "5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis." ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , İstanbul, Turkey, pp.1, 2012
Amirfallah, A. Et Al. (2012) . "5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis." ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs , İstanbul, Turkey, p.1.
@conferencepaper{conferencepaper, author={A Amirfallah Et Al. }, title={5 fluorourasil metabolic pathway genetic polymorhisms were associated with treatment related toxicity:Pharmacogenomic analysis}, congress name={ISC Conference on Innovative Therapies, New Targets, Challanges, Drugs}, city={İstanbul}, country={Turkey}, year={2012}, pages={1} }